A composition material for transmucosal delivery

Details for Australian Patent Application No. 2004206199 (hide)

Owner Magle Holding AB

Inventors Plym Forshell, Gustaf; Lidgard, Hans Henrik; Jonsson, Ingemar

Agent Wrays

Pub. Number AU-B-2004206199

PCT Pub. Number WO2004/064811

Priority 0302947-7 07.11.03 SE; 60/456,474 24.03.03 US; 0300187-2 24.01.03 SE

Filing date 23 January 2004

Wipo publication date 5 August 2004

Acceptance publication date 12 March 2009

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 25/34 (2006.01) Drugs for disorders of the nervous system

Event Publications

18 August 2005 PCT application entered the National Phase

  PCT publication WO2004/064811 Priority application(s): WO2004/064811

27 October 2005 Amendment Made

  The nature of the amendment is: Add coinventor Plym Forshell, Gustaf

12 March 2009 Application Accepted

  Published as AU-B-2004206199

9 July 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004206205-Personal cooling and heating system

2004206187-Method for inhibition of necrosis induced by neurotrophin